Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ADM buys Solae’s soy

This article was originally published in The Tan Sheet

Executive Summary

Decatur, Ill.-based Archer Daniels Midland has purchased Solae's soy isoflavone business, the firms announce Feb. 15. The acquisition includes "an extensive portfolio of U.S. patents, numerous foreign equivalents and pending applications," ADM says. The deal was reached under a settlement in an isoflavone concentrate patent infringement lawsuit Solae filed against ADM in 2003. Solae was created as a joint venture between Dupont and Bunge in January 2003 (1"The Tan Sheet" Jan. 20, 2003, In Brief)...

You may also be interested in...

DuPont/Bunge soy alliance

Joint venture Solae will focus on production of specialty proteins including soy concentrates, lecithins and isolates, partners DuPont and agribusiness company Bunge report. Firms anticipate annual revenues of more than $800 mil. for venture. St. Louis-based Solae is expected to launch this spring...

P&G Begins US Price Increases In Baby And Feminine Care, Could Expand To Health, Beauty

P&G plans up to double-digit price increases in US baby care, feminine care and adult incontinence and will analyze raw material costs and foreign exchange impacts in its other product categories for other pricing changes.

Vertex’s Price Tag For Taking More Control Of CRISPR-Partnered Candidate: At Least $900m

Vertex and partner CRISPR Therapeutics hope CDX001 can offer a single-use curative regimen for sickle cell disease and beta thalassemia patients. A regulatory filing is possible within 18-24 months.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts